Back to companies

Valneva SE

VALNFRNASDAQPharmaceuticals & Healthcare

Valneva SE

Revenue
€174.7mn
FY2025
Operating income
-€82.1mn
FY2025
Employees
—
Founded
—

Source: U.S. Securities and Exchange Commission (SEC) EDGAR Company Facts API